Close Menu

In Nature this week, investigators in Tokyo and Toronto report that "OTUB1, a deubiquitinating enzyme, is an inhibitor of DSB-induced chromatin ubiquitination." The authors write that they were surprised to find that OTUB1 binds and inhibits UBC13, consequently suppressing RNF168-dependent poly-ubiquitination "independently of its catalytic activity." The team suggests that "pharmacological targeting of the OTUB1–UBC13 interaction might enhance the DNA damage response."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.